Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

S Larré

Showing results (1-10 of 47) with videos related to

Pageof 5
Sort By:
Progres En Urologie : Journal De L'Association Francaise D'Urologie Et De La Societe Francaise D'Urologie|November 7, 2015
[Not Available]A El-Bakri, S Larré, J Eymard
Progres En Urologie : Journal De L'Association Francaise D'Urologie Et De La Societe Francaise D'Urologie|October 14, 2015
[Not Available]J Ménard, C Marchand, J Pierrevelcin, et al.
Progres En Urologie : Journal De L'Association Francaise D'Urologie Et De La Societe Francaise D'Urologie|December 10, 2019
Factors affecting guideline adherence in the initial treatment of non-muscle invasive bladder cancer: Retrospective study in a French peripheral hospitalS Jeglinschi, A Schirmann, M Durand, et al.
Progres En Urologie : Journal De L'Association Francaise D'Urologie Et De La Societe Francaise D'Urologie|April 26, 2011
[Survival is associated with time to reach PSA nadir (DAN) and the ratio DAN/nadir value after androgen deprivation for prostate cancer]A Gagnat, S Larré, G Fromont, et al.
Annales D'Urologie|February 12, 2008
[Laparoscopic approach in partial nephrectomy]A Hoznek, S Larré, L Salomon, et al.
IET Nanobiotechnology|April 19, 2011
Comparison of quantum-dots- and fluorescein-isothiocyanate-based technology for detecting prostate-specific antigen expression in human prostate cancerY Ruan, W Yu, F Cheng, et al.
Progres En Urologie : Journal De L'Association Francaise D'Urologie Et De La Societe Francaise D'Urologie|December 24, 2019
[Interest of reTURB for pTa high grade bladder urothelial carcinoma]B Branchu, P Léon, S C Jeglinschi, et al.
Progres En Urologie : Journal De L'Association Francaise D'Urologie Et De La Societe Francaise D'Urologie|May 1, 2012
[French translation and linguistic validation of the questionnaire Bladder Cancer Index (BCI)]N Gaunez, S Larré, C Pirès, et al.
Progres En Urologie : Journal De L'Association Francaise D'Urologie Et De La Societe Francaise D'Urologie|May 31, 2011
[Variation of urinary PCA3 following transrectal ultrasound-guided prostate biopsy]Y Prezelin, C Ronsin, O Celhay, et al.
Progres En Urologie : Journal De L'Association Francaise D'Urologie Et De La Societe Francaise D'Urologie|May 16, 2020
[Impact of antiplatelet and anticoagulant treatments on bleeding complications in patients treated with HoLEP]B Branchu, P Léon, R Fournier, et al.
Pageof 5

Showing results (1-10 of 47) with videos related to

Sort By:
Pageof 5
Progres En Urologie : Journal De L'Association Francaise D'Urologie Et De La Societe Francaise D'Urologie|November 7, 2015
[Not Available]A El-Bakri, S Larré, J Eymard
Progres En Urologie : Journal De L'Association Francaise D'Urologie Et De La Societe Francaise D'Urologie|October 14, 2015
[Not Available]J Ménard, C Marchand, J Pierrevelcin, et al.
Progres En Urologie : Journal De L'Association Francaise D'Urologie Et De La Societe Francaise D'Urologie|December 10, 2019
Factors affecting guideline adherence in the initial treatment of non-muscle invasive bladder cancer: Retrospective study in a French peripheral hospitalS Jeglinschi, A Schirmann, M Durand, et al.
Progres En Urologie : Journal De L'Association Francaise D'Urologie Et De La Societe Francaise D'Urologie|April 26, 2011
[Survival is associated with time to reach PSA nadir (DAN) and the ratio DAN/nadir value after androgen deprivation for prostate cancer]A Gagnat, S Larré, G Fromont, et al.
Annales D'Urologie|February 12, 2008
[Laparoscopic approach in partial nephrectomy]A Hoznek, S Larré, L Salomon, et al.
IET Nanobiotechnology|April 19, 2011
Comparison of quantum-dots- and fluorescein-isothiocyanate-based technology for detecting prostate-specific antigen expression in human prostate cancerY Ruan, W Yu, F Cheng, et al.
Progres En Urologie : Journal De L'Association Francaise D'Urologie Et De La Societe Francaise D'Urologie|December 24, 2019
[Interest of reTURB for pTa high grade bladder urothelial carcinoma]B Branchu, P Léon, S C Jeglinschi, et al.
Progres En Urologie : Journal De L'Association Francaise D'Urologie Et De La Societe Francaise D'Urologie|May 1, 2012
[French translation and linguistic validation of the questionnaire Bladder Cancer Index (BCI)]N Gaunez, S Larré, C Pirès, et al.
Progres En Urologie : Journal De L'Association Francaise D'Urologie Et De La Societe Francaise D'Urologie|May 31, 2011
[Variation of urinary PCA3 following transrectal ultrasound-guided prostate biopsy]Y Prezelin, C Ronsin, O Celhay, et al.
Progres En Urologie : Journal De L'Association Francaise D'Urologie Et De La Societe Francaise D'Urologie|May 16, 2020
[Impact of antiplatelet and anticoagulant treatments on bleeding complications in patients treated with HoLEP]B Branchu, P Léon, R Fournier, et al.
Pageof 5